We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+20.65%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
+$24.3M
(+32%)
Cap. Flow
+$6.54M
Cap. Flow
% of AUM
6.51%
Top 10 Holdings %
Top 10 Hldgs %
56.12%
Holding
218
New
50
Increased
37
Reduced
21
Closed
27
Avg Time Held Equity + Options
4.4
quarters
Top 10 Avg Time Held Equity + Options
1.9
quarters
Top 20 Avg Time Held Equity + Options
2.2
quarters
Avg Time Held Equity only
4.7
quarters
Top 10 Avg Time Held Equity only
2.6
quarters
Top 20 Avg Time Held Equity only
2.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.77M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$661K |
| 3 |
Agios Pharmaceuticals
AGIO
|
+$653K |
| 4 |
Micron Technology
MU
|
+$610K |
| 5 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$487K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.06M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$823K |
| 3 |
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
|
+$578K |
| 4 |
BVA
CORDIA BANCORP INC COM
BVA
|
+$499K |
| 5 |
Opko Health
OPK
|
+$349K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 43.64% |
| 2 | Miscellaneous | 21.13% |
| 3 | Healthcare | 14.92% |
| 4 | Technology | 7.13% |
| 5 | Consumer Discretionary | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
HCR
76
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $230K | 0.23% |
15,000
| – | – |
2016 Q2
1 quarter
|
|
|
AERI
77
DELISTED
Aerie Pharmaceuticals
AERI
| $226K | 0.23% |
+6,000
| New | +$132K |
2016 Q3
0 quarters
|
|
78
DELISTED
American Midstream Partners, LP
AMID
| $222K | 0.22% |
+15,000
| New | +$191K |
2016 Q3
0 quarters
|
|
|
SNAK
79
DELISTED
Inventure Foods, Inc.
SNAK
| $216K | 0.22% |
23,000
+5,000
| +28% | +$45.1K |
2016 Q1
2 quarters
|
|
80
DELISTED
General Motors Company
GM.WS.B
| $211K | 0.21% |
15,107
| – | – |
2013 Q2
13 quarters
|
|
81
Casella Waste Systems
CWST
$5.45B
| $206K | 0.21% |
20,000
-5,000
| -20% | -$45.6K |
2015 Q1
6 quarters
|
|
82
NeoGenomics
NEO
$2.06B
| $206K | 0.21% |
25,000
+10,000
| +67% | +$83.9K |
2014 Q2
9 quarters
|
|
|
FNM
83
DELISTED
FANNIE MAE
FNM
| $203K | 0.2% |
120,000
| – | – |
2014 Q4
7 quarters
|
|
|
LUB
84
DELISTED
Luby's Inc.
LUB
| $193K | 0.19% |
45,000
| – | – |
2013 Q2
13 quarters
|
|
|
JMP
85
DELISTED
JMP Group LLC
JMP
| $193K | 0.19% |
35,000
| – | – |
2013 Q2
13 quarters
|
|
86
DELISTED
Lindblad Expeditions Holdings Inc. Warrant
LINDW
| $185K | 0.18% |
95,300
+10,778
| +13% | +$21.6K |
2015 Q3
4 quarters
|
|
|
NVCN
87
DELISTED
Neovasc Inc.
NVCN
| $184K | 0.18% |
14
+8
| +133% | +$112K |
2016 Q2
1 quarter
|
|
88
DELISTED
Mr. Cooper
COOP
| $176K | 0.18% |
6,250
+1,250
| +25% | +$35.1K |
2015 Q3
4 quarters
|
|
89
Advanced Micro Devices
AMD
$967B
| $173K | 0.17% |
+25,000
| New | +$160K |
2016 Q3
0 quarters
|
|
90
Bloomin' Brands
BLMN
$740M
| $172K | 0.17% |
10,000
| – | – |
2016 Q1
2 quarters
|
|
|
KATE
91
DELISTED
Kate Spade & Company
KATE
| $171K | 0.17% |
+10,000
| New | +$194K |
2016 Q3
0 quarters
|
|
|
ASNA
92
DELISTED
Ascena Retail Group, Inc.
ASNA
| $168K | 0.17% |
+1,500
| New | +$227K |
2016 Q3
0 quarters
|
|
93
DELISTED
Chesapeake Energy Corporation
CHK
| $157K | 0.16% |
+125
| New | +$144K |
2016 Q3
0 quarters
|
|
|
FOMX
94
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $156K | 0.16% |
+16,843
| New | +$141K |
2016 Q3
0 quarters
|
|
|
INNL
95
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
| $154K | 0.15% |
26,506
| – | – |
2016 Q1
2 quarters
|
|
96
Permian Basin Royalty Trust
PBT
$1.67B
| $139K | 0.14% |
20,000
-5,000
| -20% | -$34.8K |
2016 Q2
1 quarter
|
|
|
SRCI
97
DELISTED
SRC Energy Inc
SRCI
| $139K | 0.14% |
+20,000
| New | +$132K |
2016 Q3
0 quarters
|
|
98
DELISTED
Southwestern Energy Company
SWN
| $138K | 0.14% |
+10,000
| New | +$139K |
2016 Q3
0 quarters
|
|
99
Lipocine
LPCN
$14.3M
| $134K | 0.13% |
1,765
| – | – |
2016 Q2
1 quarter
|
|
|
SWC
100
DELISTED
Stillwater Mining Co
SWC
| $134K | 0.13% |
+10,000
| New | +$134K |
2016 Q3
0 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q3 2016 Portfolio in Review
As of Q3 2016, E.E. Geduld held 218 positions worth $100M, up 32% from $76M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
E.E. Geduld deployed $6.54M of net new capital in Q3 2016, opening 50 new positions and adding to 37 existing holdings. Its largest new stake was Agios Pharmaceuticals: 15,000 shares worth $792K.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 49% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Opko Health, an estimated $349K trimmed.
- E.E. Geduld's largest Q3 2016 buy was Agios Pharmaceuticals: 15,000 shares worth $792K.
- E.E. Geduld added most to Bristol-Myers Squibb in Q3 2016, an estimated $1.77M increase.
- E.E. Geduld's biggest Q3 2016 reduction was Opko Health, cutting an estimated $349K.
- E.E. Geduld fully exited Tesla in Q3 2016, selling an estimated $1.06M.
- E.E. Geduld's ten largest holdings make up 56% of its $100M portfolio in Q3 2016.
- E.E. Geduld opened 50 new positions and closed 27 in Q3 2016.
- E.E. Geduld's portfolio value rose 32% quarter-over-quarter to $100M.
Based on E.E. Geduld's 13F filing for Q3 2016, filed 2 Nov 2016.